{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:33:15Z","timestamp":1773297195640,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.psychres.2011.03.020","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T13:13:19Z","timestamp":1305897199000},"page":"349-356","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness and safety of antipsychotics in early onset psychoses: A long-term comparison"],"prefix":"10.1016","volume":"189","author":[{"given":"Carlo","family":"Cianchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giuseppina","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2011.03.020_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.psychres.2011.03.020_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00787-005-0515-2","article-title":"Antipsychotics in early onset schizophrenia: systematic review and meta-analysis","volume":"15","author":"Armenteros","year":"2006","journal-title":"European Child & Adolescent Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/cap.2007.0138","article-title":"Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach","volume":"18","author":"Castro-Fornieles","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.psychres.2011.03.020_bb0020","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.psychres.2011.03.020_bb0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0030","first-page":"583","article-title":"Double-blind maintenance safety and effectiveness findings from the treatment of early-onset schizophrenia spectrum (TEOSS) study","volume":"49","author":"Findling","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/cap.2006.16.308","article-title":"Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics","volume":"16","author":"Fleischhaker","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.psychres.2011.03.020_bb0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euroneuro.2010.07.002","article-title":"Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled studies","volume":"21","author":"Fraguas","year":"2011","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2011.03.020_bb0045","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0924-977X(96)00010-7","article-title":"Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs","volume":"6","author":"Gallhofer","year":"1996","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2011.03.020_bb0050","series-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976"},{"key":"10.1016\/j.psychres.2011.03.020_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2011.03.020_bb0060","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archpsyc.1996.01830120020005","article-title":"Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison","volume":"53","author":"Kumra","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopsych.2007.04.043","article-title":"Clozapine and \"high-dose\" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison","volume":"63","author":"Kumra","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/cap.2007.0089","article-title":"Clozapine versus \"high-dose\" olanzapine in refractory early-onset schizophrenia: an open-label extension study","volume":"18","author":"Kumra","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.psychres.2011.03.020_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10578-009-0134-0","article-title":"Early-onset psychoses: comparison of clinical features and adult outcome in 3 diagnostic groups","volume":"40","author":"Ledda","year":"2009","journal-title":"Child Psychiatry and Human Development"},{"key":"10.1016\/j.psychres.2011.03.020_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2011.03.020_bb0085","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.psychres.2011.03.020_bb0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2011.03.020_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-1781(97)00129-7","article-title":"Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia","volume":"77","author":"Rodriguez","year":"1998","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2011.03.020_bb0105","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.63.7.721","article-title":"Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison","volume":"63","author":"Shaw","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300327","article-title":"A pilot study of risperidone, olanzapine and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial","volume":"29","author":"Sikich","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2011.03.020_bb0120","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/chi.0b013e31812eed10","article-title":"Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome","volume":"46","author":"Sporn","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.psychres.2011.03.020_bb0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2011.03.020_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/1044546041648977","article-title":"Chart review for potential features of myocarditis, pericarditis and cardiomyopathy in children and adolescents treated with clozapine","volume":"4","author":"Wehmeier","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178111002447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178111002447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T20:21:30Z","timestamp":1543782090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178111002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0165178111002447"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2011.03.020","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}